Sign Up for Free!

Continue Analyzing the page and more.

Already have an Account? Log In

The Trial has ended

Continue Analyzing the page and more.

Cannagistics Inc. logo
CNGT

Cannagistics Inc.

MaveScore 13 Low model confidence
Last Price US$0.00 As of Updating
Market Cap US$26600.0 Company size context
7D Performance 0.00% Past 7 days
1Y Performance 0.00% Past 12 months
Model Rating
Historical model output for research review

Fundamental data date

Apr 30, 2022

1533 days old

Market price date

Updating

Refreshing

Coverage

13/16

3 missing model inputs

Data quality

Review

Partial or delayed snapshot

Transparent research score

Why the model scores this stock

MaveScore is a research prioritization score from 0 to 100. It is historical model output for watchlist review, not personalized financial advice.

MaveScore 13 Low confidence

Stored data quality

Freshness and coverage checks

13/16 Partial or delayed snapshot

Quality

11/35 Weak

Blends latest model rank with profitability and dilution ranks.

Financial Strength

1/25 Weak

Rewards durable profitability, margins, and positive free cash flow.

Valuation Support

0/15 Weak

Favors positive earnings, positive cash flow, and lower multiples.

Momentum

0/15 Needs Data

Momentum needs recent 3-month or 6-month price-change data.

Shareholder Alignment

1/10 Weak

Rewards less dilutive share behavior and enough size for liquid research coverage.

Positive model output

More live company inputs are needed before positive research signals can be surfaced.

Research risks to review

  • Blends latest model rank with profitability and dilution ranks.
  • Rewards durable profitability, margins, and positive free cash flow.
  • Favors positive earnings, positive cash flow, and lower multiples.

MaveScore uses historical model inputs, stored company fundamentals, and stored price context for research support only. Review missing inputs and business-specific risks before acting. Missing inputs right now include latest price, 3-month price change, 6-month price change.

Dashboard Funda..tals Prediction Screener Map

Cannagistics Inc. Overview

Industry: Shell Companies

Sector: Financial Services

Cannagistics, Inc. develops, markets, and sells OTC, pharmaceutical, nutraceutical, cosmetic, and health and wellness products. Its product portfolio includes Canagel, an anhydrous hydrogel composition and delivery system; Silverpro, a compression fabric; KidzStrips, a thin film children's toothpaste strip; and ImmuniZin, an immune booster, as well as HydroSoil, a novel fertilizer. The company also provides IcyEase, an ice pack for muscle/joint pain; Slim-D, an appetite-suppressant oral strip; Energy Lighting Strips for oral energy; Micro Voltage Trans Derm C for pain; and CBD 600, a hemp rich oral tincture. It offers products in the areas of pain relief, anti-aging, hygiene, energy, and immune system and biochemical support, as well as skin creams for treatment of disorders and rejuvenations. In addition, the company provides products for veterinary and agricultural use. It offers its products through wholesale and retail establishments, including brick and mortar stores; and ecommerce platforms. The company was formerly known as Precious Investments, Inc. and changed its name to Cannagistics, Inc. in May 2019. Cannagistics, Inc. was incorporated in 2004 and is based in Hauppauge, New York. Cannagistics, Inc. develops, markets, and sells OTC, pharmaceutical, nutraceutical, cosmetic, and health and wellness products. Its product portfolio includes Canagel, an anhydrous hydrogel composition and delivery system; Silverpro, a compression fabric; KidzStrips, a thin film children's toothpast Read More

Cannagistics Inc. is evaluated based on the investment philosophy and approach to stock market investing developed by renowned investor Warren Buffett. Companies with high ratings typically exhibit growing earnings, a substantial profit margin, conservative leverage, a consistently high return on equity, and a sustained practice of repurchasing their shares over the years.

Cannagistics Inc.

Score

Reported Results

No latest earnings report cached yet

Run the EDGAR earnings refresh to load the latest company-filed earnings release, 10-Q, 10-K, or transcript exhibit for this ticker.

Recent News



Earnings Per Share

Score 2.00/5
Cannagistics Inc. earns a low score, as its Earnings Per Share (EPS) has not shown continuous growth over the last six years. Notable counterparts in the sector with high scores includes Aflac Inc Pathward Financial Inc T. Rowe Price Group Inc
In Shell Companies industry , HG Holdings, Inc. , FUEL DOCTOR HOLDINGS, INC. , PREVENTION INSURANCE COM are companies with high ratings.

Return on Equity

Score 1.97/5
Cannagistics Inc. exhibits a lower score in the Return on Equity (ROE) section, falling below the sector median value and indicating a comparatively weaker performance in this metric. The top companies in the same sector include Aflac Inc Pathward Financial Inc T. Rowe Price Group Inc
Cannagistics... CNGT US$26600
Aflac Inc AFL US$61.7b
Pathward Fin... CASH US$1.9b
T. Rowe Pric... TROW US$25.8b

Net Margin

Score 1.10/5
Cannagistics Inc. olds a low score as its net margin consistently trails below the sector median value and doesn't exhibit continuous growth over the last six years; notable companies in the sector with commendable scores include Aflac Inc Pathward Financial Inc T. Rowe Price Group Inc
Cannagistics... CNGT US$26600
Aflac Inc AFL US$61.7b
Pathward Fin... CASH US$1.9b
T. Rowe Pric... TROW US$25.8b

Share Buyback

In Shell Companies industry , HG Holdings, Inc. , FUEL DOCTOR HOLDINGS, INC. , PREVENTION INSURANCE COM are companies with high ratings.

Leverage

Score 2.99/5
Cannagistics Inc. attains a commendable score in the category due to its lower leverage ratio over the past six years in comparison to the sector median value. Additionally, other notable companies in the same sector, such as Aflac Inc Pathward Financial Inc T. Rowe Price Group Inc , also exhibit high scores.
Cannagistics... CNGT US$26600
Aflac Inc AFL US$61.7b
Pathward Fin... CASH US$1.9b
T. Rowe Pric... TROW US$25.8b

Financial Statements

Company-reported SEC EDGAR facts organized into the three core statements.

SEC financial statements are temporarily unavailable.

Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

Financial Ratio

Yearly Quarterly

Financial
Profitability
Growth
Cash Flow
Financial Health
Efficiency Ratios

Cannagistics Inc. logo

Cannagistics Inc.

US$0.00

US$26600.0

0.00%

0.00%